Jamaica Finance

Feb 28 2018

Multiple Myeloma: ESMO Clinical Practice Guidelines

#relapsed #myeloma, #multiple #myeloma


#

Sarcoma and GIST

Soft Tissue and Visceral Sarcomas • Bone Sarcomas • Gastrointestinal Stromal Tumours

Supportive and Palliative Care

Management of infusion reactions to systemic anticancer therapy • Management of toxicities from immunotherapy • Management of febrile neutropaenia • MASCC and ESMO consensus guidelines for the prevention of chemotherapy and radiotherapy-induced nausea and vomiting • Treatment of dyspnoea in advanced cancer patients • Central venous access in oncology • Management of oral and gastrointestinal mucosal injury • Management of refractory symptoms at the end of life and the use of palliative sedation • Advanced care planning in palliative care • Bone health in cancer patients • Cancer, fertility and pregnancy • Management of chemotherapy extravasation • Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy • Management of cancer pain • Management of venous thromboembolism in cancer patients • Prevention of chemotherapy and radiotherapy-induced nausea • Erythropoiesis-stimulating agents in the treatment of anaemia in cancer patients • Haematopoietic growth factors

Pocket Guidelines Mobile App

Download the new version of our App with the latest Pocket Guidelines for professionals and Guides for Patients

ESMO Guidelines Methodology

To assist those using and/or evaluating the ESMO Guidelines, download the methodology here

Guides for Patients are designed to assist patients, their relatives and caregivers to better understand the nature of different types of cancer and evaluate the best available treatment choices

Personalised Medicine Explained

Video interviews and articles designed to help patients, policy makers and other non-medical professionals better understand the principles of personalised cancer medicine

Getting the Most out of Your Oncologist

Now available in Romanian, our Guide for Patients with Advanced Cancer is designed for patients, their family members and oncologists.

Designated Centres of Integrated Oncology and Palliative Care

The ESMO Designated Centres of Integrated Oncology and Palliative Care accreditation programme recognises cancer centres which provide comprehensive services in supportive and palliative care as part of their routine care.

Patient Advocacy Track

The ESMO Patient Advocacy Track encourages communication between patients, families, oncologists and healthcare professionals.

Multiple Myeloma: ESMO Clinical Practice Guidelines


Written by admin


Leave a Reply

Your email address will not be published. Required fields are marked *